Human Microbiome Sequencing Instrument Market

Human Microbiome Sequencing Instrument Market contains market size and forecasts of Human Microbiome Sequencing Instrument in global, including the following market information:

Global Human Microbiome Sequencing Instrument Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Human Microbiome Sequencing Instrument Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Human Microbiome Sequencing Instrument companies in 2021 (%)

The global Human Microbiome Sequencing Instrument market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Reagents and Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Microbiome Sequencing Instrument include Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., Novogene Corporation and OraSure Technologies, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Human Microbiome Sequencing Instrument manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Microbiome Sequencing Instrument Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Microbiome Sequencing Instrument Market Segment Percentages, by Type, 2021 (%)

Reagents and Kits

Instruments

Liquid Handling Instruments

Cytometers

Imaging Devices

Microplate Reader

Others

Global Human Microbiome Sequencing Instrument Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Microbiome Sequencing Instrument Market Segment Percentages, by Application, 2021 (%)

Research and Academic Institutions

Pharmaceutical and Biotechnology Companies

Hospital and Clinic

Others

Global Human Microbiome Sequencing Instrument Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Human Microbiome Sequencing Instrument Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Microbiome Sequencing Instrument revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Human Microbiome Sequencing Instrument revenues share in global market, 2021 (%)

Key companies Human Microbiome Sequencing Instrument sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Human Microbiome Sequencing Instrument sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Baseclear B.V.

Beijing Genomics Institute (BGI) Genomics Co., Ltd

Charles River Laboratories International Inc.

Clinical Microbiomics A/S

Eurofins Scientific SE

GENEWIZ, Inc.

Illumina, Inc.

Novogene Corporation

OraSure Technologies, Inc.

Oxford Nanopore Technologies, Inc.

Pacific Biosciences of California, Inc.

QIAGEN N.V.

Second Genome, Inc.

Thermo Fisher Scientific Inc.

Viome, Inc.

CosmosID

Leucine Rich Bio Pvt. Ltd.

Microba

Microbiome Insights Inc.

Molzym GmbH & Co. KG